Cross-resistance to cladribine (CdA) and cytarabine (Ara-C) in human etoposide-resistant cell lines

被引：0
|
作者：
Albertioni, F [1 ]
Lotfi, K [1 ]
Wang, Y [1 ]
Xu, D [1 ]
Knaust, E [1 ]
Lillemark, E [1 ]
Eriksson, S [1 ]
机构：
[1] Karolinska Hosp, Dept Clin Pharmacol, S-17176 Stockholm, Sweden
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
562
引用
收藏
页码：147 / 147
页数：1
相关论文
共 50 条
  • [31] Structure-activity profiles of eleutherobin analogs and their cross-resistance in Taxol-resistant cell lines
    Hayley M. McDaid
    Samit K. Bhattacharya
    Xiao-Tao Chen
    Lifeng He
    Heng-Jia Shen
    Clare E. Gutteridge
    Susan Band Horwitz
    Samuel J. Danishefsky
    Cancer Chemotherapy and Pharmacology, 1999, 44 : 131 - 137
  • [32] Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents
    Magdalena Klanova
    Lucie Lorkova
    Ondrej Vit
    Bokang Maswabi
    Jan Molinsky
    Jana Pospisilova
    Petra Vockova
    Cory Mavis
    Lucie Lateckova
    Vojtech Kulvait
    Dana Vejmelkova
    Radek Jaksa
    Francisco Hernandez
    Marek Trneny
    Martin Vokurka
    Jiri Petrak
    Pavel Klener
    Molecular Cancer, 13
  • [33] Deoxycytidine kinase expression and activity in ara-C resistant cell lines and samples from newly diagnosed acute leukemias.
    Martincic, D
    Kravtsov, V
    Koury, M
    Avramis, VI
    Whitlock, JA
    BLOOD, 1997, 90 (10) : 2520 - 2520
  • [34] Downregulation of deoxycytidine kinase in cytarabine-resistant mantle cell lymphoma cells confers cross-resistance to nucleoside analogs gemcitabine, fludarabine and cladribine, but not to other classes of anti-lymphoma agents
    Klanova, Magdalena
    Lorkova, Lucie
    Vit, Ondrej
    Maswabi, Bokang
    Molinsky, Jan
    Pospisilova, Jana
    Vockova, Petra
    Mavis, Cory
    Lateckova, Lucie
    Kulvait, Vojtech
    Vejmelkova, Dana
    Jaksa, Radek
    Hernandez, Francisco
    Trneny, Marek
    Vokurka, Martin
    Petrak, Jiri
    Klener, Pavel, Jr.
    MOLECULAR CANCER, 2014, 13
  • [35] MECHANISM OF CROSS-RESISTANCE TO CISPLATIN IN A MITOMYCIN C-RESISTANT HUMAN BLADDER-CANCER CELL-LINE
    SINGH, SV
    XU, BH
    JANI, JP
    EMERSON, EO
    BECKES, MG
    RIHN, C
    SCALAMOGNA, D
    STEMMLER, N
    SPECHT, S
    BLANOCK, K
    KATOH, A
    GUPTA, V
    INTERNATIONAL JOURNAL OF CANCER, 1995, 61 (03) : 431 - 436
  • [36] Circumvention of cytarabine (Ara-C) resistance by 2-chloro-deoxyadenosine (2-CdA) in pediatric acute myeloid (AML) and acute lymphoblastic (ALL) leukemia: An in vitro study.
    Zwaan, CM
    Kaspers, GJL
    Pieters, R
    Huismans, DR
    Van Wering, ER
    Janka-Schaub, GE
    Creutzig, U
    Henze, G
    Veerman, AJP
    BLOOD, 2000, 96 (11) : 307A - 307A
  • [37] Schedule dependent synergy of suberoylanilide hydroxamic acid (SAHA or Vorinostat) in combination with Cytarabine (ara-C) and etoposide in HL-60 human acute myeloid leukemia cells
    Shiozawa, Ken
    Nakanishi, Takeo
    Tan, Ming
    Fang, Hong-Bin
    Edelman, Martin J.
    Gojo, Ivana
    Sausville, Edward
    Ross, Douglas D.
    CANCER RESEARCH, 2006, 66 (08)
  • [38] CROSS-RESISTANCE TO CYTO-TOXIC DRUGS IN HUMAN GLIOMA CELL-LINES IN CULTURE
    MERRY, S
    KAYE, SB
    FRESHNEY, RI
    BRITISH JOURNAL OF CANCER, 1984, 50 (06) : 831 - 835
  • [39] X-RAY AND CISPLATIN CROSS-RESISTANCE IN HUMAN-TUMOR CELL-LINES
    SCHWARTZ, JL
    ROTMENSCH, J
    COHEN, M
    WEICHSELBAUM, RR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1988, 29 : 341 - 341
  • [40] ALKYLATING-AGENTS - INVITRO STUDIES OF CROSS-RESISTANCE PATTERNS IN HUMAN CELL-LINES
    TEICHER, BA
    CUCCHI, CA
    LEE, JB
    FLATOW, JL
    ROSOWSKY, A
    FREI, E
    CANCER RESEARCH, 1986, 46 (09) : 4379 - 4383
12345